Skip to main content

Implications of the Tumor Immune Microenvironment for Staging and Therapeutics - Robert A. Anders, MD, PhD

Original release date:
April 28, 2020
Access to this course expires on:  February 16, 2023 at 11:59 PM Pacific Time

Faculty: Robert A. Anders, MD, PhD

Learning Objectives:
  1. Understand the value of the tumor immune microenvironment in cancer patient prognosis
  2. Discuss the use of microsatellite unstable (MSI HI) / mismatch repair deficiency testing in relation to immune based anti-cancer therapy.
  3. Gain knowledge of how newer immune based anti-cancer therapies will likely impact diagnostic pathology
  4. Explain the challenges in reporting PD-L1 immunohistochemical staining